The sequential light microscopic changes in aflatoxin B 1-induced liver tumors during chronic administration of glutathione were studied. The results suggest that necrosis of neoplastic hepatocytes plays an important role during the regression of tumor growth induced by glutathione.
INTRODUCTION
Results from this laboratory have shown that reduced glutathione (GSH) administered to rats bearing aflatoxin B I (AFB I ) induced liver tumors caused regression of tumor growth and resulted in survival of the animals (1) . The morphological part of this previous study was only concerned with the liver changes at the end of the GSH experiment. Therefore, an investigation was successively carried out in this laboratory to monitor the sequential light microscopic changes of AFB 1tea ted livers during chronic administration of GSH. Our preliminary results are the subject of the present report.
METHODS
Details on treatment of the animals and dosage of AFB I and GSH were given in previous papers (1, 2) . Briefly, tumors were induced in the liver of female Wistar rats by an 8-week carcinogenic regimen of AFB I (25 J.Lg in 40 doses over 8 weeks, by stomach intubation), a dosing regimen yielding 100 percent incidence of hepatocellular carcinomas after one year (3). 16 months after discontinuation of the carcinogen, Af'Bi-treated rats were divided into two groups: one group was started on treatment with GSH (Fluka: 100 rug/rat/ day by stomach intubation), and the other received no further treatment. Rats that received only AFB 1 were killed when moribund. Rats that received AFB 1 and GSH were randomly sacrificed in groups of 2-7 at 2, 4 and 8 months after GSH treatment was started. Detailed autopsies were performed on all animals. Livers were fixed in 10% neutral formalin along with spleen, kidney, lung and heart specimens. After fixation, all livers were cut with a razor blade in 2 mm slices to determine the total number and size of tumors. Tissues were processed by routine paraffin methods and stained with hematoxylin-eosin, van Gieson, PAS and fast cresyl violet.
RE:SULTS AND DISCUSSION
Livers of rats that had died by the time GSH treatment was started, showed a diffuse neoplastic transformation by visual examination. By light microscopy, the hepatocellular carcinomas had primarily a trabecular pattern as illustrated previously (1) . By 2 months on GSH treatment, no clear changes either in tumor incidence or in tumor size could be detected. Histologically, neoplastic hepatocytes displayed degenerative changes (Fig. la) . Cell necrosis and dissolution were usually present ( Fig. lb) . By 4 months, only small-sized neoplastic areas could be observed either by visual or light microscopic examination. Most of the liver parenchyma consisted of healthy hepatocytes arranged in cords several cell thick (Fig. lc) . Cell degeneration and cell necrosis had become a seldom finding whereas the empty spaces had increased in size and number. By 8 months on GSH treatment, all livers were free of tumor changes by gross examination. Histologically, 5 out of 7 rats killed at this time showed no evidence of liver pathology.
Our results suggest that necrosis of neoplastic hepatocytes plays an important role during the regression of tumor growth induced by GSH. Livers of normal rats given an equivalent amount of GSH showed no mor-phological changes when examined by light or electron microscopy (1) . It may imply that the lethal effect of GSH is selectively directed against malignant cells. Experiments are currently under way in this laboratory to investigate the mechanism producing lethal injury of neoplastic hepatocytes by GSH. It is interesting that vitamin C was also reported to selectively kill malignant cells (4), an observation suggesting a common mechanism of action for antioxidant compounds.
Tumor Regression by GSH DISCUSSION DR. BANNASCH: Dr. Novi, may I ask you what was your control system? Perhaps I have missed that point. Since we know that basophilic cells which are rich in ribosomes under the influence of carcinogens may change to become nearly normal again after withdrawal of the carcinogen. It would be important to know what your control system was with respect to treatment with glutathione.
Dr. Novi: Probably you missed the first part of my talk where I showed in detail the characteristics of my control system. Control rats for the experiments with glutathione were given aflatoxin B I only and let die spontaneously. As I reported in a previous paper (Science: 212, 541, 1981), our aflatoxin BI dosing regimen induces hepatocellular carcinomas in 100 percent of the rats with all animals dying of liver tumor by 20 months after cessation of the carcinogen treatment. Under our experimental conditions livers of rats treated only with aflatoxin B1 undergo a progressive increase of basophilia which is diffusely extended at the time the animals die. A regression of basophilia was only observed in liver of surviving rats under additional treatment with glutathione.
DR. DE LA IGLESIA: I think one of the most important determinants for the feasibility of your hypothesis of the SER-rich cells versus the mitochondria-rich cells is somehow an idea of the ratio of the population of these cells in the tissue. Have you attempted to get some quantitation on whether this is just a spurious phenomenon or it is consistently a factor that you can find in terms of cells that appear because that will mean that there is a differentiation of cells into one type or another?
DR. NOVI: The results I have shown summarize a common pattern of changes occurring in a large number of liver specimens from each rat. Smooth endoplasmic reticulum-rich cells prevail over mitochondria-rich cells even at an earlier time during glutathione administration. A differentiation of mitochondriarich into smooth endoplasmic reticulum-rich cells is especially evident during the first two months on glutathione treatment when the majority of cells show intermediate features between these two types of cells.
DR. FARBER: This is obviously very interesting. You're postulating then that the afla-
